Condor Energies Inc
F:WQ6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Condor Energies Inc
F:WQ6
|
CA |
|
T
|
Takeda Pharmaceutical Co Ltd
XHAM:TKD
|
JP |
|
R
|
RS Group PLC
DUS:ECN
|
UK |
|
W
|
Wabash National Corp
F:WA9
|
US |
|
G
|
Goosehead Insurance Inc
F:2OX
|
US |
|
B
|
Botanix Pharmaceuticals Ltd
OTC:BXPHF
|
AU |
|
Century Lithium Corp
XTSX:LCE
|
CA |
Wall St Price Targets
WQ6 Price Targets Summary
Condor Energies Inc
According to Wall Street analysts, the average 1-year price target for WQ6 is 1.65 EUR with a low forecast of 1.14 EUR and a high forecast of 2.03 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is WQ6's stock price target?
Price Target
1.65
EUR
According to Wall Street analysts, the average 1-year price target for WQ6 is 1.65 EUR with a low forecast of 1.14 EUR and a high forecast of 2.03 EUR.
What is the Revenue forecast for Condor Energies Inc?
Projected CAGR
-24%
Over the last 13 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 3 years is -24%.
What is the Operating Income forecast for Condor Energies Inc?
Projected CAGR
45%
The compound annual growth rate for Operating Income over the next 2 years is 45%.
